Table 3.
Variable | Exacerbation | |||
---|---|---|---|---|
Baseline | Follow-Up After 5 Years | |||
Moderate-to-Severe Exacerbation | Severe Exacerbation | Moderate-to-Severe Exacerbation | Severe Exacerbation | |
Total, n | 3.5±4.4 | 0.1±0.4 | 4.7±5.0 | 0.1±0.3 |
No MetS | 3.4±4.5 | 0.1±0.4 | 4.6±5.1 | 0.1±0.3 |
MetS | 3.6±4.2 | 0.1±0.3 | 4.9±4.6 | 0.1±0.02 |
P value | 0.41 | 0.97 | 0.10 | 0.59 |
Men | ||||
No MetS | 3.3±4.6 | 0.1±0.4 | 4.5±5.2 | 0.1±0.3 |
MetS | 3.2±4.0 | 0.1±0.3 | 4.5±4.6 | 0.1±0.2 |
P value | 0.50 | 0.23 | 0.78 | 0.43 |
Women | ||||
No MetS | 3.7±4.3 | 0.1±0.3 | 4.9±4.9 | 0.1±0.2 |
MetS | 4.5±4.6 | 0.1±0.5 | 5.8±4.4 | 0.1±0.2 |
P value | 0.03 | 0.14 | 0.02 | 0.85 |
Note: Data are expressed as mean±standard deviation.
Abbreviations: COPD, chronic obstructive pulmonary disease; MetS, metabolic syndrome.